Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/BF01806133.pdf
Reference28 articles.
1. Soule HD, Vasquez J, Lang A, Albert S, Brennan NA: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409–1413, 1973
2. Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ: Establishment and characterisation of cell line of human breast carcinoma origin. Eur J Cancer 15: 659–670, 1979
3. Vignon F, Bardon S, Chalbos D, Rochefort H: Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer. J Clin Endocrinol Metab 56: 1124–1130, 1983
4. Horwitz KB: The antiprogestin RU38486: Receptor mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47D human breast cancer cells. Endocrinology 116: 2236–2245, 1985
5. Rochefort H, Bardon S, Chalbos D, Vignon F: Steroidal and non steroidal antiestrogens in breast cancer cells in culture. J Steroid Biochem 20: 105–110, 1984
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antiprogestins in gynecological diseases;REPRODUCTION;2015-01
2. Hormonal prevention of breast cancer;Annales d'Endocrinologie;2014-07
3. The anti-progestin RU-486 inhibits viability of MCF-7 breast cancer cells by suppressing WNT1;Cancer Letters;2011-12
4. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models;Steroids;2009-04
5. Clearance of dying autophagic cells of different origin by professional and non-professional phagocytes;Cell Death & Differentiation;2007-03-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3